Benzinga Rankings give you vital metrics on any stock – anytime.
Explore SPDR Series Trust SPDR S&P Biotech ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XBI.
Open | - |
High | - |
52 Wk High | $105.47 |
AUM | 5.69B |
Dividend | $0.26 |
Ex-Div Date | Jun 24, 2024 |
Volume | 660 |
Market Cap | $25.98B |
Mgmt Fee | 0.35% |
P/E Ratio | 18.30 |
Prev. Close | $87.11 |
Low | - |
52 Wk Low | $81.14 |
Shares Out | 75.22M |
Yield | 0.27% |
Div. Freq | Quarterly |
Avg. Volume Daily | 8.45M |
Beta | 0.95 |
Avg. Expense Ratio | 0.35% |
P/B Ratio | 3.86 |
You can purchase shares of SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.
There are no as such competitors for SPDR Series Trust SPDR S&P Biotech ETF.
There is no analysis for SPDR Series Trust SPDR S&P Biotech ETF to provide a consensus price target.
The stock price for SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI) is $87.7 last updated March 24, 2025 at 4:07 AM EDT.
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on September 26, 2018 to stockholders of record on September 21, 2018.
SPDR Series Trust SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.
There is no upcoming split for SPDR Series Trust SPDR S&P Biotech ETF.
Open | - |
High | - |
52 Wk High | $105.47 |
AUM | 5.69B |
Dividend | $0.26 |
Ex-Div Date | Jun 24, 2024 |
Volume | 660 |
Market Cap | $25.98B |
Mgmt Fee | 0.35% |
P/E Ratio | 18.30 |
Prev. Close | $87.11 |
Low | - |
52 Wk Low | $81.14 |
Shares Out | 75.22M |
Yield | 0.27% |
Div. Freq | Quarterly |
Avg. Volume Daily | 8.45M |
Beta | 0.95 |
Avg. Expense Ratio | 0.35% |
P/B Ratio | 3.86 |
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Small Cap Growth |
Fund Inception | Jan 31, 2006 |
Managers | Raymond Donofrio Michael Feehily John A. Tucker Karl A. Schneider |
Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
NVAX | Novavax Inc | 3.06% |
INSM | Insmed Inc | 2.61% |
MRNA | Moderna Inc | 1.53% |
NTRA | Natera Inc | 1.33% |
DYN | Dyne Therapeutics Inc | 1.33% |
RVMD | Revolution Medicines I... | 1.32% |
PTCT | Ptc Therapeutics Inc | 1.29% |
BPMC | Blueprint Medicines Co... | 1.27% |
UTHR | United Therapeutics Co... | 1.26% |
AMGN | Amgen Inc. | 2.88% |
GILD | Gilead Sciences Inc | 3.18% |
ABBV | Abbvie Inc. | 3.07% |
BMRN | Biomarin Pharmaceutica... | 2.73% |
VRTX | Vertex Pharmaceuticals... | 2.62% |
INCY | Incyte Corp. | 2.46% |
ALNY | Alnylam Pharmaceutical... | 2.43% |
HALO | Halozyme Therapeutics ... | 2.37% |
BIIB | Biogen Inc. | 2.28% |